No abstract available
MeSH terms
-
Adalimumab
-
Adult
-
Aged
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized / adverse effects
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Antirheumatic Agents / adverse effects
-
Antirheumatic Agents / therapeutic use*
-
Arthritis, Psoriatic / complications
-
Arthritis, Psoriatic / drug therapy*
-
Etanercept
-
Female
-
Humans
-
Immunoglobulin G / adverse effects
-
Immunoglobulin G / therapeutic use
-
Infections / etiology*
-
Infliximab
-
Male
-
Middle Aged
-
Receptors, Tumor Necrosis Factor / therapeutic use
-
Recurrence
-
Severity of Illness Index
-
Spondylarthritis / complications
-
Spondylarthritis / drug therapy*
-
Spondylitis, Ankylosing / complications
-
Spondylitis, Ankylosing / drug therapy*
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antirheumatic Agents
-
Immunoglobulin G
-
Receptors, Tumor Necrosis Factor
-
Infliximab
-
Adalimumab
-
Etanercept